Growing Number of Travelers to keep Demand for Vaccines on the Upswing during Forecast Period

Published Date : Dec 19, 2016

Albany, NY, Dec 19, 2016: The research report, titled “Global Travel Vaccines Market 2016-2020,” provides a clear understanding of the nature of the market and its scope for growth. The document includes an reports of the historical data and the present-day market situation. For a comprehensive understanding of the subject, the report has been compiled using primary and secondary research methodologies. The information has been collected through trusted sources and has been authenticated with quotes and comments. 

According to the research report, the global travel vaccines market is estimated to surge at a CAGR of 6.83% during the forecast period of 2016 and 2020. The steady CAGR of the global market is being driven by the growing demand for getting vaccinated amongst travelers. The need to steer clear of possible infections and diseases in foreign lands is encouraging travelers to get appropriately vaccinated. The market is also being driven by government mandates to ensure travelers are vaccinated as per the norms set by the foreign countries to prevent cross contamination. The growing number of travelers over the coming few years due to rising disposable incomes are also poised to boost the revenue of the global market. 

Some of the vaccines studied in this research report are typhoid, rabies, meningococcal disease, Japanese encephalitis, hepatitis B, hepatitis A, and yellow fever. The geographies studied in this research report are the Americas, Asia Pacific, Europe, and the Middle East and Africa. The analysts have identified the strengths, weaknesses, opportunities, and threats impacting these segments of the global market. The report also documents the region-specific growth patterns of these segments and provides an evaluation their trajectory for the coming few years. 

For Sample Copy, click here: 

The market is likely to be challenged by the shortage of these vaccines and a poor distribution system. The high cost of developing these vaccines is also expected to restrain the growth of this market in the coming few years. Furthermore, the stringent regulatory framework for prescribing these vaccines and developing is also holding the market back from achieving its potential growth. 

Some of the leading players operating in the global travel vaccines market are GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Pfizer, Sanofi, Indian Immunologicals, JN International Medical, LG Life Sciences, Kaketsuken, Lupin, Mitsubishi Tanabe Pharma, Novavax, Panacea Biotec, and Nuron Biotech. The research report provides an assessment of these players and ascertains the nature of the competitive landscape. The analysts have chronicled the financial outlook, research and development activities, and business and marketing strategies of these companies for the coming few years. The document aims to offer a microscopic view to its readers to help them understand the market dynamics in complete detail. 

To order report Call Toll Free: 866-997-4948 or send an email on